Total Payments
$1,411
2024 Payments
$79.90
Companies
22
Transactions
89
Medicare Patients
5,007
Medicare Billing
$525,972
Payment Breakdown by Category
Food & Beverage$1,376 (97.5%)
Education$34.95 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,376 | 88 | 97.5% |
| Education | $34.95 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $299.43 | 21 | $0 (2024) |
| AbbVie Inc. | $242.74 | 16 | $0 (2023) |
| Lilly USA, LLC | $225.34 | 14 | $0 (2023) |
| PFIZER INC. | $125.03 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $66.08 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $59.33 | 4 | $0 (2024) |
| Smith+Nephew, Inc. | $52.61 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $52.12 | 3 | $0 (2022) |
| Amgen Inc. | $51.75 | 4 | $0 (2023) |
| Abbott Laboratories | $42.07 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79.90 | 4 | Novo Nordisk Inc ($39.12) |
| 2023 | $289.16 | 16 | Lilly USA, LLC ($104.72) |
| 2022 | $339.40 | 19 | ABBVIE INC. ($157.89) |
| 2021 | $225.63 | 14 | Lilly USA, LLC ($56.89) |
| 2020 | $213.87 | 16 | Novo Nordisk Inc ($165.49) |
| 2019 | $81.83 | 5 | PFIZER INC. ($34.95) |
| 2018 | $136.99 | 11 | PFIZER INC. ($51.49) |
| 2017 | $44.65 | 4 | Daiichi Sankyo Inc. ($12.01) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Respiratory | ||||||
| 03/08/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: WOMENS HEALTH | ||||||
| 08/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 08/14/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Inflammation | ||||||
| 08/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Diabetes | ||||||
| 08/01/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 07/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Diabetes | ||||||
| 05/24/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 04/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Oncology | ||||||
| 04/12/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: VACCINES | ||||||
| 02/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Diabetes | ||||||
| 02/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Diabetes | ||||||
| 02/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Endocrinology | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 09/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,281 | 3,210 | $266,319 | $123,721 |
| 2022 | 18 | 1,248 | 2,847 | $262,719 | $136,827 |
| 2021 | 21 | 1,298 | 2,942 | $282,470 | $155,806 |
| 2020 | 18 | 1,180 | 2,791 | $254,480 | $109,617 |
Total Patients
5,007
Total Services
11,790
Medicare Billing
$525,972
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 614 | $113,590 | $49,637 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 121 | 217 | $47,740 | $25,580 | 53.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 143 | 143 | $22,880 | $17,289 | 75.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 132 | 287 | $43,050 | $16,555 | 38.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 82 | 82 | $4,920 | $4,822 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 109 | 347 | $10,410 | $3,248 | 31.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 134 | 134 | $2,680 | $2,287 | 85.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 89 | 89 | $2,314 | $2,268 | 98.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 19 | 20 | $920.00 | $692.40 | 75.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 14 | $770.00 | $567.70 | 73.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 20 | $760.00 | $214.80 | 28.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 69 | 555 | $5,670 | $198.79 | 3.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 11 | 12 | $120.00 | $117.60 | 98.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 33 | $330.00 | $72.60 | 22.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 13 | 16 | $160.00 | $51.36 | 32.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 73 | 474 | $7,110 | $39.34 | 0.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 30 | $600.00 | $31.41 | 5.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 19 | 75 | $375.00 | $29.47 | 7.9% |
| J1940 | Injection, furosemide, up to 20 mg | Office | 2023 | 14 | 48 | $1,920 | $20.47 | 1.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 173 | 394 | $86,650 | $46,891 | 54.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 475 | $87,875 | $42,088 | 47.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 150 | 150 | $24,000 | $18,642 | 77.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 181 | $27,150 | $12,089 | 44.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 68 | 68 | $4,080 | $3,998 | 98.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 17 | $3,992 | $3,149 | 78.9% |
About Dr. John Tucker, M.D
Dr. John Tucker, M.D is a Family Medicine healthcare provider based in Scottsboro, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457347130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Tucker, M.D has received a total of $1,411 in payments from pharmaceutical and medical device companies, with $79.90 received in 2024. These payments were reported across 89 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,376).
As a Medicare-enrolled provider, Tucker has provided services to 5,007 Medicare beneficiaries, totaling 11,790 services with total Medicare billing of $525,972. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Scottsboro, AL
- Active Since 09/27/2005
- Last Updated 10/05/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457347130
Products in Payments
- Ozempic (Drug) $242.22
- MOUNJARO (Drug) $122.19
- VRAYLAR (Drug) $109.60
- UBRELVY (Drug) $80.23
- JARDIANCE (Drug) $72.06
- GRAFIX PL (Medical Supply) $52.61
- ENTRESTO (Drug) $52.12
- LINZESS (Drug) $38.84
- EUCRISA (Drug) $34.95
- TRELEGY ELLIPTA (Drug) $33.32
- SHINGRIX (Biological) $32.76
- PREMARIN (Drug) $25.95
- Aimovig (Biological) $25.13
- CHANTIX (Drug) $23.95
- AYVAKIT (Drug) $23.33
- Rybelsus (Drug) $22.87
- FREESTYLE LIBRE 2 (Device) $22.20
- Victoza (Drug) $21.81
- TLANDO (Drug) $21.27
- LOKELMA (Drug) $20.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Scottsboro
Mandi Allen-Bell, Md, MD
Family Medicine — Payments: $17,164
Family Medicine $17,164
Dr. Charles Bradford, M.d, M.D
Family Medicine — Payments: $9,263
Family Medicine $9,263
Dr. Charles Bradford, M.d, M.D
Family Medicine — Payments: $8,882
Family Medicine $8,882
Mark Cooper, M.d, M.D
Family Medicine — Payments: $2,453
Family Medicine $2,453
Margaret Belue, Md, MD
Family Medicine — Payments: $1,981
Family Medicine $1,981
Christopher Clayton, M.d, M.D
Family Medicine — Payments: $1,865
Family Medicine $1,865